Summer Clinical Practice Test

The main idea is that for nebulized SABA therapy, the standard per-dose amount is a fixed, effective amount that provides rapid bronchodilation with a favorable safety profile. This per-dose amount is 2.5 mg delivered by nebulization. Nebulization delivers albuterol as a fine mist, allowing the medication to reach the lower airways quickly—helpful when a patient is having a significant bronchospasm or cannot use an inhaler effectively. In acute settings, clinicians often repeat this 2.5 mg dose every 20 minutes for up to three doses, reassessing after each to decide on further treatment. Smaller fixed doses, like 1.25 mg, are not the standard for most adults and are less commonly used in routine SABA therapy, while larger doses (5 mg or 10 mg) are not routinely given as a single dose due to increased risk of adverse effects such as tachycardia and tremor.